MEDP
Medpace Holdings, Inc.
$669.20
+2.33%
2026-10-23
About Medpace Holdings, Inc.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Key Fundamentals
P/E Ratio
36.36
Forward P/E
32.05
EPS (TTM)
$17.02
ROE
162.2%
Revenue Growth (YoY)
17.2%
Profit Margin
17.7%
Debt/Equity
33.22
Price/Book
39.81
Beta
1.15
Market Cap
$17.27B
Avg Volume (10D)
277K
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$684.52
60D Low
$563.45
Avg Volume
259K
Latest Close
$669.20
Get breakout alerts for MEDP
Sign up for Breakout Scanner to receive daily notifications when MEDP triggers breakout signals. Build custom AI screeners and backtest strategies.
Create your account7-day free trial, no card needed. Then $20/month.
Medpace Holdings, Inc. (MEDP) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors MEDP daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. MEDP operates in the Healthcare sector within the Diagnostics & Research industry. Data is provided for informational purposes only and does not constitute financial advice.